Myokardia, inc. (MYOK)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flow from operating activities:
Net loss

-69,868

-58,767

-141,802

-38,174

-37,470

-15,676

-15,789

-18,413

-17,820

-10,066

-16,721

-15,461

-14,762

17,031

-9,231

-9,760

-8,420

-7,909

-5,462

-5,075

-4,500

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

10,752

9,100

8,275

8,638

6,981

5,702

5,226

4,782

3,631

1,791

1,601

1,341

1,405

1,032

763

604

414

270

142

69

35

Depreciation

800

500

500

400

500

500

400

400

300

323

343

318

316

296

284

275

256

224

248

239

254

Amortization of discount on investments

418

585

378

364

292

152

74

55

-2

-23

-21

-19

-22

-

-

-

-

-

-

-

-

Loss on disposal of equipment

-49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

0

0

15

Change in fair value of redeemable convertible preferred stock call option liability, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

314

Change in operating assets and liabilities:
Receivable from collaboration partner

-

-

-

-

-

-2,565

2,565

0

-1,013

1,013

0

0

-45,000

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-226

155

3,279

-374

-448

2,194

-38

284

444

331

303

-571

419

632

-304

-179

-37

660

56

-177

313

Operating lease right-of-use assets

-1,066

-611

-728

-644

-635

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-

-459

294

-138

13

209

29

-88

146

-90

69

-25

105

-

-

-

-

-

-

-

-

Accounts payable

-467

-525

3,308

-1,669

1,950

314

-341

486

212

139

716

-1,117

629

-62

64

-321

-115

888

-86

176

323

Accrued liabilities

-1,512

-3,037

10,274

4,608

-180

1,845

5,712

2,645

-1,257

939

559

3,083

-1,613

2,223

977

716

-666

1,851

623

395

71

Prepayment from collaboration partner

-

0

2,256

843

9,874

-2,030

-1,828

-1,414

-3,269

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-504

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

0

3,297

-698

-692

-45

-45

-45

-43

-2

-32

-42

-44

-34

-32

-32

-11

-49

136

60

307

Deferred revenue

-

-

-

-

-

-12,400

-9,188

-6,639

-5,331

-2,954

-3,077

-3,001

-2,410

38,678

-3,549

-3,550

-3,550

-3,550

-3,550

-3,549

-3,550

Net cash used in operating activities

-59,897

-52,857

-123,785

-27,081

-38,046

-17,787

-14,816

-15,598

-16,614

-6,631

-16,962

-14,264

28,019

13,508

-10,420

-11,889

-12,055

-8,923

-7,967

-7,508

-7,702

Purchases of investments

-

114,105

104,199

8,896

32,697

84,054

8,826

7,846

31,749

0

8,022

4,002

32,020

-

-

-

-

-

-

-

-

Sales of investments

4,000

0

0

0

4,000

-

-

-

-

0

0

0

4,000

-

-

-

-

-

-

-

-

Maturities of investments

96,475

31,000

18,000

13,000

16,000

12,000

4,000

4,000

8,000

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

12,627

1,286

285

880

813

356

661

1,168

1,188

600

300

432

185

229

88

204

562

72

93

719

562

Proceeds from sale of equipment

-

-

-

-

-

-

-

-

39

-

-

-

-

-

-

-

-

0

0

0

134

Net cash provided by (used in) investing activities

87,848

-84,391

-86,484

3,224

-13,510

-72,410

2,513

-5,053

-24,898

3,410

-8,322

-4,434

-28,205

-16,289

-88

-204

-562

-72

-93

-659

-428

Proceeds from issuance of common stock in follow-on offerings, net of issuance and financing costs

-

0

0

-261

271,485

-

-

-

-

-

-

-

-

-

-

-

-

-

224

29

99

Payments of financing related costs

-

-

-

-

-

-

-

-

-

-

0

0

38

-

-

0

153

-

-

-

-

Proceeds from exercise of stock options and employee stock purchase plan

1,817

3,498

1,736

1,557

280

1,040

2,818

1,544

806

697

1,238

409

21

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,817

3,498

1,736

1,296

271,765

1,040

2,612

183,613

806

634

135,163

409

-17

61,428

13

213

-153

56,715

-471

45,626

99

Net increase in cash, cash equivalents and restricted cash

29,768

-133,750

-208,533

-22,561

220,209

-89,157

-9,691

162,962

-40,706

-2,587

109,879

-18,289

-203

58,647

-10,495

-11,880

-12,770

47,720

-8,531

37,459

-8,031

Non-cash investing and financing activities:
Unpaid portion of property and equipment purchases included in period-end accounts payable and accrued liabilities

2,015

8,067

1,672

-553

570

310

-228

69

317

245

-180

139

79

96

-5

-6

18

13

21

-21

48

Vesting of early exercised options and restricted stock

-

0

0

7

8

9

12

14

18

28

57

45

54

46

46

109

71

57

46

45

29

Unpaid financing-related costs

-

-

-

-251

262

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid portion of property and equipment purchases included in period-end accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-219

229

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

26

29

33

Accretion of dividends on redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

621

1,900

1,678

952